logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yusuke Sasaki

hokkaido university
H指数:23
被引数:1,922

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictors of the early discontinuation of anamorelin hydrochloride in gastrointestinal cancer-related cachexia: a multicenter retrospective cohort study (HGCSG2201)

盐酸安莫妙早期停药预测因素：胃肠道癌相关恶病质的多中心回顾性队列研究（HGCSG2201）

Supportive Care in Cancer
IF3
2026-02-190
PRE
Kazuaki Harada; Shinya Kajiura; Kentaro Sawada; Kazuteru Hatanaka; Atsushi Sato; Ken Ito; Hotaka Tamura; Ayako Doi; Takayuki Ando; Michio Nakamura; Hiroshi Nakatsumi; Tetsuhito Muranaka; Susumu Sogabe; Takahiro Ishii; Shintaro Nakano; Masayoshi Dazai; Yusuke Sasaki; Yasuyuki Kawamoto; Satoshi Yuki; Yuh Sakata; Yoshito Komatsu
A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-08-142
OA
Nakatsumi, Hiroshi; Komatsu, Yoshito; Harada, Kazuaki; Kawamoto, Yasuyuki; Yuki, Satoshi; Sawada, Kentaro; Ishiguro, Atsushi; Sogabe, Susumu; Ando, Takayuki; Sasaki, Yusuke; Yoshikawa, Ayumu; Nakamura, Michio; Dazai, Masayoshi; Tateyama, Miki; Muto, Osamu; Kotaka, Masahito; Sagawa, Tamotsu; Muranaka, Tetsuhito; Hatanaka, Kazuteru; Takagi, Ryo; Sakata, Yu
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies
FRONTIERS IN ONCOLOGY
IF3.3
2022-11-091
OAAI
Nakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, Yu
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of first-line treatment
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
OAAI
Ito, K.; Yuki, S.; Nakano, S.; Yagisawa, M.; Sawada, K.; Ishiguro, A.; Muto, O.; Hatanaka, K.; Okuda, H.; Sato, A.; Sasaki, Y.; Nakamura, M.; Sasaki, T.; Kobayashi, T.; Dazai, M.; Nakatsumi, H.; Ueda, A.; Tateyama, M.; Sogabe, S.; Matsumoto, R.; Sakata, Y.; Komatsu, Y.
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
OAAI
Kaneko, S.; Ito, K.; Yuki, S.; Harada, K.; Yagisawa, M.; Sawada, K.; Ishiguro, A.; Muto, O.; Hatanaka, K.; Okuda, H.; Sato, A.; Sasaki, Y.; Nakamura, M.; Sasaki, T.; Tsuji, Y.; Ando, T.; Kato, K.; Wakabayashi, T.; Kotaka, M.; Takahashi, Y.; Sakata, Y.; Komatsu, Y.
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
PREAI
Yoshikawa, A.; Ito, K.; Yuki, S.; Kawamoto, Y.; Saito, R.; Yamamura, T.; Yagisawa, M.; Ishiguro, A.; Muto, O.; Hatanaka, K.; Okuda, H.; Sato, A.; Sasaki, Y.; Nakamura, M.; Sasaki, T.; Kobayashi, T.; Dazai, M.; Nakatsumi, H.; Ueda, A.; Sakata, Y.; Komatsu, Y.
HGCSG1801: A phase II trial of 2nd-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibody

HGCSG1801: 二线FOLFIRI联合阿柏西普治疗抗EGFR抗体难治性转移性结直肠癌患者的II期试验

ANNALS OF ONCOLOGY
IF65.4
2020-07-010
OAAI
Shindo, Y.; Nakatsumi, H.; Yuki, S.; Kawamoto, Y.; Muto, O.; Dazai, M.; Harada, K.; Kobayashi, Y.; Sogabe, S.; Katagiri, M.; Kotaka, M.; Nakamura, M.; Hatanaka, K.; Ishiguro, A.; Tsuji, Y.; Kobayashi, T.; Tateyama, M.; Sasaki, Y.; Sasaki, T.; Takagi, R.; Sakata, Y.; Komatsu, Y.
Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists
CHEMMEDCHEM
IF3.4
2019-11-058
PREAI
Sato, Ayumu; Fukase, Yoshiyuki; Kono, Mitsunori; Ochida, Atsuko; Oda, Tsuneo; Sasaki, Yusuke; Ishii, Naoki; Tomata, Yoshihide; Fukumoto, Shoji; Imai, Yumi N.; Uga, Keiko; Shibata, Akira; Yamasaki, Masashi; Nakagawa, Hideyuki; Shirasaki, Mikio; Skene, Robert; Hoffman, Isaac; Sang, Bi-Ching; Snell, Gyorgy; Shirai, Junya; Yamamoto, Satoshi

研究方向

暂未获取到该数据
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万
M
Masayoshi Dazai
H 指数:5论文数:109被引数:368
H
Hiroshi Nakatsumi
H 指数:7论文数:135被引数:242
S
Satoshi Yuki
H 指数:24论文数:460被引数:2,274
O
Osamu Muto
H 指数:8论文数:95被引数:247
K
Kazuaki Harada
H 指数:9论文数:155被引数:253
K
Kazuteru Hatanaka
H 指数:13论文数:200被引数:615
Y
Yasuyuki Kawamoto
H 指数:18论文数:218被引数:1,889
M
Michio Nakamura
H 指数:32论文数:264被引数:3,789
S
Susumu Sogabe
H 指数:10论文数:92被引数:377